Steve Bernstein
Analyst · the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this conference call. It is now my pleasure to introduce your host, Thomas McClelland, President and Chief Executive Officer
Thank you, Tom, and good afternoon. For the six months ended October 31, 2023, consolidated revenue was $25.9 million compared to $17.2 million for the same period of the prior fiscal year. The components of revenue are as follows. Revenue from commercial and US Government satellite programs was approximately $9.5 million or 37% compared to $7.8 million or 46% in the same period of the prior fiscal year. Revenues on satellite payload contracts are recognized primarily under the percentage of completion method and are recorded only in the FEI New York segment. Revenues from non-space, US Government, and DOD customers, which are recorded in both the FEI New York and FER Zyfer segments, were $15.8 million compared to $8 million in the same period of the prior fiscal year and accounted for approximately 58% of consolidated revenue compared to 47% for the prior fiscal year. Other commercial industrial revenue was $1.4 million for the six months ending October 31st, ‘23 and ‘22. The significant increase in revenue for the period compared to the same period in the previous fiscal year was related to contract awards, resolution of technical problems from the previous fiscal year, and improvements made by management. For the sixth month ended October 31, ‘23, gross margin and gross margin rate increased as compared to the same period of fiscal year ‘23. The gross margin dollar increased as a direct result of increase in revenue. The gross margin rate increased significantly due to the fact that many of the technical challenges faced in the prior fiscal year have been resolved and as a result the related programs are now moving forward and running more efficiently. Previous programs that sustained lower margins due to technical issues are near completion or have completed. For the six months ending October 31, ‘23 and ‘22, SG&A expenses were approximately 19% and 23% respectively of consolidated revenue. The percentage of consolidated revenue decreased 5% due to an increase in sales for the six months ending October 31st, ‘23 as compared to the six months ending October 31st, ‘22. The increase in SG&A expense for the six months ending October 31st, ‘23 as compared to the prior year period was largely due to an increase in professional fees, payroll, and associated costs. R&D expense for the six months ending October 31st, ‘23 decreased to $1.3 million from $1.7 million for the six months period ending October 31st, ‘22, a decrease of $400,000 and were approximately 5% and 10% respectively of consolidated revenue. R&D decrease for the six months ending October 31, ‘23 was primarily due to a shift of employees between production and development depending upon availability, scheduling, and necessity. The company plans to continue to invest in R&D in the future to keep its products at a state of the art. For the six months ending October 31, ‘23, the company recorded operating income of $3 million compared to an operating loss of $5.4 million in the prior year. Operating income increased due to a combination of increase in revenue, gross margin, and the effects of cost-cutting measures instituted by management that began in fiscal year ‘23. Other income can be derived from reclaiming of metals, refunds, interest on deferred trust assets or the sale of fixed assets, interest expenses related to deferred compensation payments made to retired employees. This yields pre-tax income of approximately $2.9 million compared to a $5.4 million pre-tax loss for the prior fiscal year. For the six months ending October 31, ‘23, the company recorded a tax provision of $13,000 compared to $2,000 for the same period of the prior fiscal year. Consolidated net income for the six-month ending October 31, ‘23 was $2.8 million, or $0.30 per share, compared to a $5.4 million loss, or $0.58 per share in the previous fiscal year. Our fully funded backlog at the end of October ‘23 was approximately $50 million compared to $56 million for the previous fiscal year ending April 30, 2023. The company's balance sheet continues to reflect a strong working capital position of approximately $25 million at October 31st, ’23, and a current ratio of approximately 2 to 1. Additionally, the company is debt free. The company believes that its liquidity is adequate to meet its operating and investing needs for the next 12 months and the foreseeable future. I will turn the call back to Tom and we look for your questions soon.